We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Hits CytoDyn With Partial Clinical Hold in HIV and Full Clinical Hold in COVID-19
FDA Hits CytoDyn With Partial Clinical Hold in HIV and Full Clinical Hold in COVID-19
The FDA has placed a partial clinical hold on CytoDyn’s human immunodeficiency virus (HIV) program and a full clinical hold on its COVID-19 program in the U.S.